| Literature DB >> 35889756 |
Na Wang1,2, Jie Lu2, Yan Zhao2, Yuan Wei2, Jenny Gamble3, Debra K Creedy3.
Abstract
Preterm birth is a leading cause of neonatal and child mortality and morbidity worldwide. The aim of this study was to investigate associations between attending a brief antenatal lifestyle education seminar and preterm birth, and whether education timing modifies outcomes. A retrospective cohort study was conducted in a hospital-based antenatal care center in Beijing, China, where a free, 2 h, optional, face-to-face, midwife-led group seminar on healthy lifestyle choices during pregnancy was provided. Among the 3008 eligible women, 1107 (36.8%) attended the seminar during the first trimester, 515 (17.1%) attended during the second trimester or later, and 1386 (46.1%) did not attend. Multiparous women were more likely to not attend or to attend at a later stage. The overall prevalence of preterm birth was 8.7%, but it was higher for women who did not attend the antenatal seminar (11.5%). The risk of preterm birth for first trimester attendees decreased by 53%, and it decreased by 41% for later attendees. Estimates persisted after adjusting pre-existing and gestational covariates. Attending a brief antenatal lifestyle education seminar was associated with lower preterm birth risk, and attending during the first trimester had a better impact than later attendance. The results can inform the development of tailored preterm birth prevention strategies.Entities:
Keywords: antenatal education; health promotion; intervention timing; lifestyle factors; preterm birth
Mesh:
Year: 2022 PMID: 35889756 PMCID: PMC9325292 DOI: 10.3390/nu14142799
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Study cohort flowchart.
Maternal characteristics and seminar attendance.
| Variables | Seminar Attendance | F/χ2 |
| ||
|---|---|---|---|---|---|
| Absence | 1st Trimester ( | 2nd Trimester or Later ( | |||
|
| |||||
| Age | 7.580 | 0.023 | |||
| <35 | 836 (60.3) | 726 (65.6) | 316 (61.4) | ||
| ≥35 | 550 (39.7) | 381 (34.4) | 199 (38.6) | ||
| Obese | 0.181 | 0.913 | |||
| Yes | 32 (2.3) | 23 (2.1) | 12 (2.3) | ||
| No | 1354 (97.7) | 1084 (97.9) | 503 (97.7) | ||
| Parity | 137.206 | 0.000 | |||
| Nulliparous | 752 (54.3) | 851 (76.9) | 331 (64.5) | ||
| Multiparous | 634 (45.7) | 256 (23.1) | 183 (35.5) | ||
| Prior CS/myomectomy | 59.889 | 0.000 | |||
| Yes | 321 (23.3) | 124 (11.2) | 94 (18.3) | ||
| No | 1065 (76.8) | 983 (88.8) | 421 (81.7) | ||
| Prior cervical surgery | 0.772 | 0.680 | |||
| Yes | 14 (1.0) | 10 (0.9) | 3 (0.6) | ||
| No | 1372 (99.0) | 1097 (99.1) | 512 (99.4) | ||
| Prior preterm birth | 3.706 | 0.157 | |||
| Yes | 19 (1.4) | 7 (0.6) | 4 (0.8) | ||
| No | 1367 (98.6) | 1100 (99.4) | 511 (99.2) | ||
| Pre-existing diabetes | 2.846 | 0.241 | |||
| Yes | 36 (2.6) | 23 (2.1) | 18 (3.5) | ||
| No | 1350 (97.4) | 1084 (97.9) | 497 (96.5) | ||
| Chronic hypertension 1 | 6.754 | 0.034 | |||
| Yes | 52 (3.8) | 26 (2.3) | 24 (4.7) | ||
| No | 1334 (96.2) | 1081 (97.7) | 491 (95.3) | ||
| PCOS 2 | 2.282 | 0.319 | |||
| Yes | 43 (3.1) | 24 (2.2) | 16 (3.1) | ||
| No | 1343 (96.9) | 1083 (97.8) | 499 (96.9) | ||
| IVF/ICSI 3 | 7.570 | 0.023 * | |||
| Yes | 143 (10.3) | 154 (13.9) | 62 (11.9) | ||
| No | 1243 (89.7) | 953 (86.1) | 453 (88.1) | ||
|
| |||||
| GDM 4 | 1.983 | 0.371 | |||
| Yes | 367 (26.5) | 301 (27.2) | 153 (29.7) | ||
| No | 1019 (73.5) | 806 (72.8) | 362 (70.3) | ||
| Gestational hypertension without significant proteinuria | 2.732 | 0.255 | |||
| Yes | 72 (5.2) | 43 (3.9) | 21 (4.1) | ||
| No | 1314 (94.8) | 1064 (96.1) | 494 (95.9) | ||
| Preeclampsia or eclampsia | 5.494 | 0.064 | |||
| Yes | 66 (4.8) | 33 (3.0) | 24 (4.7) | ||
| No | 1320 (95.2) | 1074 (97.0) | 491 (95.3) | ||
| Placenta implantation | 53.388 | 0.000 | |||
| Yes | 72 (5.2) | 6 (0.5) | 7 (1.4) | ||
| No | 1314 (94.8) | 1101 (99.5) | 508 (98.6) | ||
| Incompetence of cervix uteri | 0.441 | 0.802 | |||
| Yes | 26 (1.9) | 21 (1.9) | 12 (2.3) | ||
| No | 1360 (98.1) | 1086 (98.1) | 503 (97.7) | ||
1 Defined as pre-existing hypertension or developed before 20 weeks of pregnancy; 2 PCOS: Polycystic Ovary Syndrome; 3 IVF/ICSI: in vitro fertilization or intracytoplasmic sperm injection; 4 GDM: gestational diabetes mellitus. * p < 0.05
Preterm birth rates stratified by maternal characteristics.
| Variables |
| Preterm Birth | F/χ2 |
|
|---|---|---|---|---|
|
| ||||
| Absence | 1386 | 160 (11.5) | 27.539 | 0.000 |
| 1st trimester | 1107 | 64 (5.8) | ||
| 2nd trimester or later | 515 | 37 (7.2) | ||
|
| ||||
| Age | 9.423 | 0.002 | ||
| <35 | 1878 | 140 (7.5) | ||
| ≥35 | 1130 | 121 (10.7) | ||
| Obese | 12.911 | 0.000 | ||
| Yes | 67 | 14 (20.9) | ||
| No | 2941 | 247 (8.4) | ||
| Parity | 16.342 | 0.000 | ||
| Nulliparous | 1935 | 138 (7.1) | ||
| Multiparous | 1073 | 123 (11.5) | ||
| Prior CS/myomectomy | 53.313 | 0.000 | ||
| Yes | 539 | 90 (16.7) | ||
| No | 2469 | 171 (6.9) | ||
| Prior cervical surgery | 1.295 | 0.202 | ||
| Yes | 27 | 4 (14.8) | ||
| No | 2981 | 257 (8.6) | ||
| Prior preterm birth | 4.903 | 0.027 | ||
| Yes | 30 | 6 (20.0) | ||
| No | 2978 | 255 (8.6) | ||
| Pre-existing diabetes | 4.758 | 0.029 | ||
| Yes | 77 | 12 (15.6) | ||
| No | 2931 | 249 (8.5) | ||
| Chronic hypertension | 62.830 | 0.000 | ||
| Yes | 102 | 31 (30.4) | ||
| No | 2906 | 230 (7.9) | ||
| PCOS 1 | 2.256 | 0.133 | ||
| Yes | 83 | 250 (8.5) | ||
| No | 2925 | 11 (13.3) | ||
| IVF/ICSI 2 | 0.592 | 0.442 | ||
| Yes | 359 | 35 (9.7) | ||
| No | 2649 | 226 (8.5) | ||
|
| ||||
| GDM 3 | 5.253 | 0.022 | ||
| Yes | 821 | 87 (10.6) | ||
| No | 2187 | 174 (8.0) | ||
| Gestational hypertension without significant proteinuria | 0.470 | 0.493 | ||
| Yes | 136 | 14 (10.3) | ||
| No | 2872 | 247 (8.6) | ||
| Preeclampsia or eclampsia | ||||
| Yes | 123 | 49 (39.8) | 157.146 | 0.000 |
| No | 2885 | 212 (7.3) | ||
| Placenta implantation | 239.893 | 0.000 | ||
| Yes | 85 | 47 (55.5) | ||
| No | 2923 | 214 (7.3) | ||
| Incompetence of cervix uteri | 17.207 | 0.000 | ||
| Yes | 59 | 14 (23.7) | ||
| No | 2949 | 247 (8.4) | ||
1 PCOS: Polycystic Ovary Syndrome; 2 IVF/ICSI: in vitro fertilization or intracytoplasmic sperm injection; 3 GDM: gestational diabetes mellitus.
Stepwise binary logistic regression of correlations between seminar attendance and preterm birth.
| Seminar Attendance |
| Preterm Birth Rate (%) | Model A | Model B | Model C | |
|---|---|---|---|---|---|---|
| All cohorts | 3008 | 8.7 | ||||
| Absence | 1386 | 11.5 | 1 | 1 | 1 | |
| 1st trimester | 1107 | 5.8 | 0.47 (0.35–0.64) | 0.54 (0.39–0.73) | 0.61 (0.43–0.85) | |
| 2nd trimester or later | 515 | 7.2 | 0.59 (0.41–0.86) | 0.58 (0.40–0.86) | 0.60 (0.40–0.91) | |
| Age < 35 | 1878 | 7.5 | ||||
| Absence | 836 | 10.8 | 1 | 1 | 1 | |
| 1st trimester | 726 | 5.1 | 0.45 (0.30–0.66) | 0.47 (0.31–0.71) | 0.54 (0.35–0.86) | |
| 2nd trimester or later | 316 | 4.1 | 0.36 (0.20–0.65) | 0.33 (0.18–0.62) | 0.41 (0.21–0.79) | |
| Age ≥ 35 | 1130 | 10.7 | ||||
| Absence | 550 | 12.7 | 1 | 1 | 1 | |
| 1st trimester | 381 | 7.1 | 0.52 (0.33–0.83) | 0.60 (0.37–0.94) | 0.68 (0.41–1.13) | |
| 2nd trimester or later | 199 | 12.1 | 0.94 (0.57–1.54) | 0.94 (0.56–1.56) | 0.91 (0.52–1.59) | |
| Parity = 0 | 1935 | 7.1 | ||||
| Absence | 752 | 9.7 | 1 | 1 | 1 | |
| 1st trimester | 851 | 5.5 | 0.54 (0.37–0.80) | 0.56 (0.38–0.82) | 0.57 (0.38–0.86) | |
| 2nd trimester or later | 332 | 5.4 | 0.53 (0.31–0.91) | 0.53 (0.31–0.91) | 0.50 (0.28–0.88) | |
| Parity ≥ 1 | 1073 | 11.5 | ||||
| Absence | 634 | 13.7 | 1 | 1 | 1 | |
| 1st trimester | 256 | 6.6 | 0.45 (0.26–0.77) | 0.46 (0.26–0.80) | 0.72 (0.35–1.19) | |
| 2nd trimester or later | 183 | 10.4 | 0.73 (0.43–1.23) | 0.65 (0.37–1.14) | 0.81 (0.40–1.39) | |
| Prior CS/myomectomy | 539 | 16.7 | ||||
| Absence | 321 | 20.6 | 1 | 1 | 1 | |
| 1st trimester | 124 | 10.5 | 0.45 (0.24–0.85) | 0.47 (0.25–0.89) | 0.86 (0.41–1.81) | |
| 2nd trimester or later | 94 | 11.7 | 0.51 (0.26–1.02) | 0.48 (0.24–0.97) | 0.59 (0.26–1.32) | |
| IVF/ICSI 4 | 359 | 9.7 | ||||
| Absence | 143 | 8.4 | 1 | 1 | 1 | |
| 1st trimester | 154 | 9.1 | 1.09 (0.49–2.45) | 1.20 (0.50–2.84) | 1.47 (0.57–3.80) | |
| 2nd trimester or later | 62 | 14.5 | 1.85 (0.74–4.66) | 2.32 (0.88–6.10) | 2.79 (0.94–8.25) | |
1 Model A: unadjusted analysis.; 2 Model B: analysis adjusted for pre-pregnancy factors (i.e., age, obese, parity, prior CS or myomectomy, prior preterm birth, prior diabetes, chronic hypertension and the usage of assisted reproductive technology; 3 Model C: analysis adjusted for pre-existing maternal characteristics (same as Model B) and during-pregnancy factors (i.e., GDM, preeclampsia or eclampsia, placenta implantation or incompetence of cervix); 4 IVF/ICSI: in vitro fertilization or intracytoplasmic sperm injection.